Emad I. Wafa

510 total citations
19 papers, 404 citations indexed

About

Emad I. Wafa is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Emad I. Wafa has authored 19 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Immunology and 3 papers in Organic Chemistry. Recurrent topics in Emad I. Wafa's work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (6 papers) and Synthesis and biological activity (3 papers). Emad I. Wafa is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (6 papers) and Synthesis and biological activity (3 papers). Emad I. Wafa collaborates with scholars based in United States, Egypt and Thailand. Emad I. Wafa's co-authors include Aliasger K. Salem, Sean M. Geary, Balaji Narasimhan, Kareem Ebeid, Jonathan T. Goodman, Youssef W. Naguib, Prakash Kshirsagar, Michael J. Wannemuehler, Surinder K. Batra and Gamal El‐Din A. Abuo‐Rahma and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Small.

In The Last Decade

Emad I. Wafa

19 papers receiving 400 citations

Peers

Emad I. Wafa
Maya K. Monroe United States
Michelle K. Greene United Kingdom
Galya Warren United States
Utsarga Adhikary United States
Pengkai Wu China
Kareem Ebeid United States
Adam B. Fessler United States
Jung Yeon Park South Korea
Yuan-Chin Hsieh Taiwan
Tam Nguyen United States
Maya K. Monroe United States
Emad I. Wafa
Citations per year, relative to Emad I. Wafa Emad I. Wafa (= 1×) peers Maya K. Monroe

Countries citing papers authored by Emad I. Wafa

Since Specialization
Citations

This map shows the geographic impact of Emad I. Wafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emad I. Wafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emad I. Wafa more than expected).

Fields of papers citing papers by Emad I. Wafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emad I. Wafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emad I. Wafa. The network helps show where Emad I. Wafa may publish in the future.

Co-authorship network of co-authors of Emad I. Wafa

This figure shows the co-authorship network connecting the top 25 collaborators of Emad I. Wafa. A scholar is included among the top collaborators of Emad I. Wafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emad I. Wafa. Emad I. Wafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Naguib, Youssef W., Emad I. Wafa, Sanjib Saha, et al.. (2023). A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer. Biomaterials. 296. 122093–122093. 12 indexed citations
2.
Naguib, Youssef W., Emad I. Wafa, Sanjib Saha, et al.. (2023). Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer. Small. 20(41). e2302931–e2302931. 11 indexed citations
3.
Petronek, Michael S., Joseph M. Caster, Jeffrey M. Stolwijk, et al.. (2023). Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate. Redox Biology. 62. 102651–102651. 12 indexed citations
4.
Wafa, Emad I., et al.. (2022). Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine. Science Advances. 8(29). eabk3150–eabk3150. 27 indexed citations
5.
Wafa, Emad I., et al.. (2022). Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews. 189. 114482–114482. 37 indexed citations
6.
El‐Hafeez, Amer Ali Abd, Kareem Ebeid, Aml I. Mekkawy, et al.. (2022). New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1346–1363. 41 indexed citations
7.
Liu, Luman, Prakash Kshirsagar, Shailendra K. Gautam, et al.. (2022). Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics. 12(3). 1030–1060. 91 indexed citations
8.
Al‐Qurayshi, Zaid, Emad I. Wafa, Henry T. Hoffman, Kristi Chang, & Aliasger K. Salem. (2021). Tissue‐engineering the larynx: Effect of decellularization on human laryngeal framework and the cricoarytenoid joint. Journal of Biomedical Materials Research Part B Applied Biomaterials. 109(12). 2030–2040. 5 indexed citations
9.
Wafa, Emad I., Kareem Ebeid, Sean M. Geary, et al.. (2021). Thiophene Derivative‐Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly. Advanced Therapeutics. 4(7). 12 indexed citations
10.
Al‐Qurayshi, Zaid, et al.. (2021). Tissue Engineering the Pinna: Comparison and Characterization of Human Decellularized Auricular Biological Scaffolds. ACS Applied Bio Materials. 4(9). 7234–7242. 5 indexed citations
11.
Mekkawy, Aml I., Youssef W. Naguib, Emad I. Wafa, et al.. (2021). Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice. International Journal of Pharmaceutics. 606. 120876–120876. 18 indexed citations
12.
Wongrakpanich, Amaraporn, et al.. (2020). Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine. Bioconjugate Chemistry. 31(9). 2147–2157. 14 indexed citations
13.
El‐Damasy, Ashraf K., Ghada S. Hassan, Emad I. Wafa, et al.. (2020). Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design, Synthesis, In Vitro, and In Vivo Anticancer Evaluation. ACS Pharmacology & Translational Science. 3(5). 965–977. 13 indexed citations
14.
Wilson‐Welder, Jennifer H., Paola M. Boggiatto, Jarlath E. Nally, et al.. (2020). Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms. Vaccine. 38(18). 3464–3473. 13 indexed citations
15.
Wafa, Emad I., Jennifer H. Wilson‐Welder, Richard L. Hornsby, et al.. (2020). Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral Antigens. Biomacromolecules. 21(2). 534–544. 9 indexed citations
16.
Wafa, Emad I., Sean M. Geary, Kathleen A. Ross, et al.. (2019). Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine. Nanomedicine Nanotechnology Biology and Medicine. 21. 102055–102055. 13 indexed citations
17.
Wafa, Emad I., Sean M. Geary, Kathleen A. Ross, et al.. (2018). Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses. Journal of Pharmacology and Experimental Therapeutics. 370(3). 855–863. 18 indexed citations
18.
Wafa, Emad I., Sean M. Geary, Jonathan T. Goodman, Balaji Narasimhan, & Aliasger K. Salem. (2017). The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response. Acta Biomaterialia. 50. 417–427. 43 indexed citations
19.
Wafa, Emad I., et al.. (2016). Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines. Methods in molecular biology. 1494. 201–213. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maya K. Monroe Breakdown of academic impact, for papers by Michelle K. Greene Breakdown of academic impact, for papers by Galya Warren Breakdown of academic impact, for papers by Utsarga Adhikary Breakdown of academic impact, for papers by Pengkai Wu Breakdown of academic impact, for papers by Kareem Ebeid Breakdown of academic impact, for papers by Adam B. Fessler Breakdown of academic impact, for papers by Jung Yeon Park Breakdown of academic impact, for papers by Yuan-Chin Hsieh Breakdown of academic impact, for papers by Tam Nguyen
Rankless by CCL
2026